U.S. Physical Therapy (NYSE:USPH) Stock Passes Above 200 Day Moving Average – Here’s What Happened

U.S. Physical Therapy, Inc. (NYSE:USPHGet Free Report)’s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $81.77 and traded as high as $85.43. U.S. Physical Therapy shares last traded at $84.5750, with a volume of 105,246 shares trading hands.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Monday, December 15th. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, January 21st. JPMorgan Chase & Co. decreased their price objective on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a research note on Monday, November 24th. Finally, Barrington Research reiterated an “outperform” rating and issued a $103.00 target price on shares of U.S. Physical Therapy in a research note on Monday, January 5th. Four equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and an average price target of $105.33.

Read Our Latest Report on U.S. Physical Therapy

U.S. Physical Therapy Price Performance

The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $1.29 billion, a P/E ratio of 35.54, a PEG ratio of 3.53 and a beta of 1.30. The company has a fifty day simple moving average of $81.56 and a two-hundred day simple moving average of $81.77.

Hedge Funds Weigh In On U.S. Physical Therapy

Several institutional investors have recently modified their holdings of the stock. Envestnet Asset Management Inc. grew its stake in U.S. Physical Therapy by 9.4% in the 2nd quarter. Envestnet Asset Management Inc. now owns 346,160 shares of the company’s stock valued at $27,070,000 after buying an additional 29,671 shares during the last quarter. Allspring Global Investments Holdings LLC acquired a new stake in U.S. Physical Therapy during the third quarter worth approximately $845,000. Index Fund Advisors Inc. bought a new stake in shares of U.S. Physical Therapy during the second quarter worth approximately $352,000. Geode Capital Management LLC boosted its holdings in shares of U.S. Physical Therapy by 1.2% during the second quarter. Geode Capital Management LLC now owns 352,923 shares of the company’s stock worth $27,602,000 after acquiring an additional 4,306 shares during the period. Finally, Bank of New York Mellon Corp grew its position in shares of U.S. Physical Therapy by 4.9% in the second quarter. Bank of New York Mellon Corp now owns 131,556 shares of the company’s stock valued at $10,288,000 after purchasing an additional 6,190 shares during the last quarter.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.

Further Reading

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.